About the Advanced Regenerative Manufacturing Institute
Our mission is to advance the bioeconomy of the United States. The Institute’s work will positively impact not only manufacturing but also healthcare and education and workforce development for the nation.
Manufacturing scalability, process and partnership.
There are 400,000 people worldwide right now on waiting lists for organs. What if we could create lungs, livers or corneas at scale? It would be unprecedented.
Our goal is to move highly specialized regenerative medicine – engineering or regenerating human cells, tissues and organs – from lab to production to cure diseases and improve quality of life.
ARMI’s Leadership Team
DEAN KAMEN
Executive Director & Chairman of the Board, ARMI
Maureen Toohey
Deputy Executive Director & Secretary of the Board
Thomas Bollenbach, Ph.D.
Chief Technology Officer
Jim Scott
Chief Administrative Officer
Jennifer MacDonald, M.D.
Chief Operating Officer
News Highlights
Events
-
-
Careers of Tomorrow – Museum of Science, Boston
Museum of Science 1 Science Pk, Boston, MA, United StatesThe ARMI Education & Workforce Development (EWD) team will participate in the Careers of Tomorrow event at the Museum of Science in Boston on Saturday, December 6, 2025, from 9:00
-
-
Advanced Therapies Week 2026
San Diego Convention Center & Hilton San Diego Bayfront 1 Park Boulevard,, San Diego, CA, United StatesARMI | BioFabUSA is partnering with Phacilitate for Advanced Therapies Week 2026 in San Diego — connecting members with global leaders in cell and gene therapy manufacturing. Members can reach out to their Account Manager for an exclusive registration discount.
-
-
Defense Manufacturing Conference (DMC) 2025
Caribe Royale Orlando 8101 World Center Drive, Orlando, FL, United StatesBioFabUSA will exhibit and present at DMC 2026, sharing how scalable biomanufacturing can strengthen U.S. defense capabilities and support resilient manufacturing systems.
-
-
RAPID + TCT 2026
Boston Convention Center 415 Summer St, Boston, MA, United StatesARMI will attend RAPID + TCT 2026 to explore the intersection of additive manufacturing and biomanufacturing, driving innovation in regenerative healthcare solutions.
